851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody

• Sara Fritzell,
• Michelle Nelson,
• Robert Miller,
• Catherine McMahan,
• David Bienvenue,
• Gabriela Hernandez-Hoyos,
• Anneli Nilsson,
• Lill Ljung,
• Allison Chunyk,
• Maria Askmyr

Affiliations

Sara Fritzell

2Alligator Bioscience, Lund, Sweden

Michelle Nelson

2Medical University of South Carolina, Charleston, SC, USA

Robert Miller

Aptevo Therapeutics, Seattle, WA, USA

Catherine McMahan

Aptevo Therapeutics, Seattle, WA, USA

David Bienvenue

Aptevo Therapeutics, Seattle, WA, USA

Gabriela Hernandez-Hoyos

Aptevo Therapeutics, Seattle, WA, USA

Anneli Nilsson

2Alligator Bioscience, Lund, Sweden

Lill Ljung

2Alligator Bioscience, Lund, Sweden

Allison Chunyk

1Aptevo Therapeutics, Seattle, WA, USA

Maria Askmyr

2Alligator Bioscience, Lund, Sweden